Methodologic Advances in Evaluating Abuse Deterrent Opioid Analgesics: Physician and Pharmacist Surveys

FDA BAA-17-00123
Methodological Advances in Evaluating Abuse Deterrent Opioid Analgesics
Pharmacist Survey Email Invitation
Email subject: Action Requested: Survey on Abuse-deterrent Formulation Opioids
Email body:
Dear Pharmacist,
On behalf of the U.S. Food and Drug Administration, researchers from University of Kentucky Colleges
of Pharmacy and Public Health are conducting a survey to collect information and opinions related to the
dispensing of abuse-deterrent formulation opioid analgesics. As a licensed pharmacist with the authority
to dispense controlled substances in the state of Kentucky, you are receiving this email invitation to
participate in the survey. We hope you will consider completing the survey as the information that you
provide may help us better understand how abuse-deterrent formulation opioids are being utilized in
practice. This is an anonymous survey using an encrypted website. Your email address will not be
captured nor used in any way and you will not be contacted regarding your answers to this survey. The
survey should take approximately 10 minutes to complete.
The survey can be accessed at the following link:
_________________________________

Thank you for considering the request to complete this survey.